TITLE

Asthma in Canada: missing the treatment targets

AUTHOR(S)
Chapman, Kenneth R.
PUB. DATE
April 2008
SOURCE
CMAJ: Canadian Medical Association Journal;4/8/2008, Vol. 178 Issue 8, p1027
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses a study which reported a rising rate of deaths caused by asthma at a time when physicians were complacent about their ability to manage this commonplace disease. Investigations in Canada showed that patients and their physicians relied too heavily on quick-fix bronchodilators while ignoring effective preventive therapies. It suggests that as many as one in five Canadians with asthma use rapid-acting bronchodilators more often than recommended. It concludes that although there is a decrease in asthma mortality in Canada, the majority of Canadians with asthma do not enjoy the control of symptoms recommended by guidelines.
ACCESSION #
31495277

 

Related Articles

  • Budesonide/Formoterol: A Review of its Use as Maintenance and Reliever Inhalation Therapy in Asthma. McCormack, Paul L.; Lyseng-Williamson, Katherine A. // Drugs;2007, Vol. 67 Issue 16, p2407 

    The use of combination budesonide/formoterol dry powder inhaler (Symbicort® Turbuhaler®) for both daily maintenance therapy and as-needed relief of breakthrough symptoms using a single inhaler is a new approach to asthma management that is indicated in patients with persistent asthma not...

  • Timing is everything. Ellis, Clare // Nature Reviews Drug Discovery;May2004, Vol. 3 Issue 5, p387 

    Looks at the study conducted by Richard Bond, et al, published in the 2004 issue of the "Proceedings of the National Academy of Sciences," indicating that beta-blockers which are presently contraindicated for asthmatics, might actually be able to prevent serious attacks. Influence of the...

  • International correlations between indicators of prevalence, hospital admissions and mortality for asthma in children. HR Anderson; R Gupta; V Kapetanakis; MI Asher; T Clayton; CF Robertson; DP Strachan; The ISAAC Steering Committee // International Journal of Epidemiology;Jun2008, Vol. 37 Issue 3, p573 

    Background There are extensive data on the prevalence of childhood asthma world-wide but the relationships between asthma symptom prevalence, mortality and hospital admissions have not been investigated. Methods The International Study of Asthma and Allergies in Childhood (ISAAC) used a standard...

  • Treating Acute Asthma with Antibiotics – Not Quite Yet. Little, Frédéric F. // New England Journal of Medicine;4/13/2006, Vol. 354 Issue 15, p1632 

    The article focuses on various issues related to the treatment of asthma, with special reference to a study on the treatment of asthma with telithromycin. It is mentioned that the root cause of asthma is not known, and the available treatments target facets of the underlying pathologic...

  • Inhaled corticosteroids are first-line control for asthma. Zablocki, Elaine // Managed Healthcare Executive;Jul2009, Vol. 19 Issue 7, p19 

    The article presents a study which evaluates the effectiveness of inhaled corticosteroids in managing asthma. Result of a study shows that asthmatic patients who spend time with a healthcare professional developing a personalized self- management plan will improved medication compliance and...

  • Potential Adverse Effects of Bronchodilators in the Treatment of Airways Obstruction in Older People: Recommendations for Prescribing. Gupta, Preeti; O'Mahony, M. Sinead // Drugs & Aging;2008, Vol. 25 Issue 5, p415 

    Asthma and chronic obstructive pulmonary disease (COPD) are common disorders that are associated with increasing morbidity and mortality in older people. Bronchodilators are used widely in patients with these conditions, but even when used in inhaled form can have systemic as well as local...

  • Review: formoterol increases serious adverse events in children and adults with chronic asthma. Peters, Jay // Evidence Based Medicine;Jun2009, Vol. 14 Issue 3, p12 

    The article presents a study which compares the effects of inhaled formoterol once or twice daily for 12 weeks with placebo or short-acting beta 2 agonists in treating children and adults with chronic asthma. Result shows that both can cause mortality and can cause non-fatal serious adverse...

  • Independent Nurse: Clinical - Asthma - Case study - When mild asthma might kill. Matthews, Heather // GP: General Practitioner;10/7/2005, p124 

    This article presents a case study of a 21-year-old landscape gardener who has had mild asthma since the age of 12. There is perhaps a general perception that mild asthma is not a serious condition, but recent research raises the possibility of anaphylactic sudden death in atopic patients, even...

  • WHEN SHOULD ASTHMATICS INCREASE STEROIDS? Crockett, Anthony // Pulse;4/20/2006, Vol. 66 Issue 16, p48 

    The article focuses on when patients with asthma can increase their inhaled steroids. It suggests starting or increasing the high-dose inhaled bronchodilators and possibly short courses of oral steroids. A short course of oral steroids or very high-dose of inhaled steroids can be tried if the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics